Acadian Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $23K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $145K | Buy |
|
|||||
|
2024
Q2 | $110K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.74M | Buy |
|
|||||
|
2022
Q1 | $1.99M | Buy |
|
|||||
|
2021
Q4 | $658K | Hold |
|
|||||
|
2021
Q3 | $721K | Hold |
|
|||||
|
2021
Q2 | $647K | Sell |
|
|||||
|
2021
Q1 | $808K | Sell |
|
|||||
|
2020
Q4 | $18M | Sell |
|
|||||
|
2020
Q3 | $34.8M | Sell |
|
|||||
|
2020
Q2 | $30.1M | Sell |
|
|||||
|
2020
Q1 | $24.1M | Sell |
|
|||||
|
2019
Q4 | $39.4M | Sell |
|
|||||
|
2019
Q3 | $55.8M | Sell |
|
|||||
|
2019
Q2 | $68.5M | Sell |
|
|||||
|
2019
Q1 | $87.9M | Sell |
|
|||||
|
2018
Q4 | $78.8M | Sell |
|
|||||
|
2018
Q3 | $125M | Sell |
|
|||||
|
2018
Q2 | $110M | Sell |
|
|||||
|
2018
Q1 | $109M | Buy |
|
|||||
|
2017
Q4 | $98.1M | Buy |
|
|||||
|
2017
Q3 | $76M | Buy |
|
|||||
|
2017
Q2 | $50.3M | Sell |
|
|||||
|
2017
Q1 | $81.1M | Buy |
|
|||||
|
2016
Q4 | $61.2M | Sell |
|
|||||
|
2016
Q3 | $134M | Sell |
|
|||||
|
2016
Q2 | $143M | Sell |
|
|||||
|
2016
Q1 | $139M | Buy |
|
|||||
|
2015
Q4 | $146M | Buy |
|
|||||
|
2015
Q3 | $112M | Buy |
|
|||||
|
2015
Q2 | $107M | Sell |
|
|||||
|
2015
Q1 | $126M | Sell |
|
|||||
|
2014
Q4 | $106M | Sell |
|
|||||
|
2014
Q3 | $108M | Sell |
|
|||||
|
2014
Q2 | $100M | Buy |
|
|||||
|
2014
Q1 | $25.5M | Buy |
|
|||||
|
2013
Q4 | $7.52M | Buy |
|